Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06781580 · ClinicalTrials.gov registry record · NA
Ergonomic Protocol for Competitive E-Sport Athletes
A NA study of No Disease or Condition is Being Studied, sponsored by University of Nevada, Las Vegas.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06781580: Recruiting NA study of No Disease or Condition is Being Studied, sponsored by University of Nevada, Las Vegas.
NCT06781580 is a NA study of No Disease or Condition is Being Studied that is actively recruiting participants, run by University of Nevada, Las Vegas. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06781580, a NA study of No Disease or Condition is Being Studied, is actively recruiting participants, sponsored by University of Nevada, Las Vegas.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn if this ergonomic protocol can improve performance and reduce ergonomic risk in esports athletes. It will also learn about the insight of esports athletes and their experience in implementing this new protocol. The main questions it aims to answer are: Does this ergonomic protocol improve performance? Does this ergonomic protocol reduce ergonomic risk? Researchers will assign the protocol to esports athletes who meet inclusion criteria and express interest in participating in the study. A pre-post design will be conducted to note any differences. Participants will: * Participate in a 6-week study with 4 in-person visits * Volunteers will be requested to participate in a focus group during Week 6. * Implement the strengthening protocol 3x a week and a warm up/cool down protocol before and after each gaming session. * Attend one educational session about gaming ergonomics during Week 1 * Complete the Rapid Entire Body Assessment, Kovaaks Asessment, and a Questionnaire during Week Zero, Week 3, and Week 6.
Primary Outcome
The REBA is a standardized ergonomic assessment tool used to evaluate the risk of musculoskeletal strain associated with specific body postures and tasks. In this study, the REBA is used to analyze the participants' gaming postures, focusing on key areas such as the neck, back, shoulders, arms, and wrists. Scores are generated based on observed postures and movements, with higher scores indicating greater ergonomic risk. This outcome measure helps identify and quantify changes in participants' e
Conditions Studied
Interventions
- OTHER Esports Ergonomic Protocol
Study Locations (1)
Nevada
- University of Nevada, Las Vegas - Las Vegas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-02-01 |
| Est. Completion | 2025-04 |
| Phase | NA |
What NCT06781580 shows while recruiting
NCT06781580 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with No Disease or Condition is Being Studied appearing as the primary indexed condition, and to 1 intervention - of which Esports Ergonomic Protocol is the first listed.
NCT06781580 reports a single indexed study location in Nevada.
Frequently Asked Questions
What is clinical trial NCT06781580 about?
NCT06781580 is a clinical study titled "Ergonomic Protocol for Competitive E-Sport Athletes". The goal of this clinical trial is to learn if this ergonomic protocol can improve performance and reduce ergonomic risk in esports athletes. It will also learn about the insight of esports athletes and their experience in implementing this new protocol. The main questions it aims to answer are: Do...
What is the current status of trial NCT06781580?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-02-01. Estimated completion is 2025-04.
What conditions does trial NCT06781580 study?
This clinical trial studies the following conditions: No Disease or Condition is Being Studied.
What interventions are being tested in trial NCT06781580?
The interventions under investigation include: Esports Ergonomic Protocol (OTHER).
Who is sponsoring clinical trial NCT06781580?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06781580 being conducted?
This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for No Disease or Condition is Being Studied
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06781580's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI